Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Active substance factsheet - Last updated: 22/03/2024
N-cyclopropyl-1,3,5-triazine-2,4,6-triamine (Cyromazine)
Substance name:
EC number:
266-257-8
CAS number:
66215-27-8
IUPAC name:
N2-cyclopropyl-1,3,5-triazine-2,4,6-triamine
BAS number:
1334
Product-type:
PT18
Candidate for substitution:
No
Regulatory categorisation:
Review programme substance
Approval/Assessment status:
Approved
2 related products
BEG Larva C2 Ultra BEG Madenstop Ultra But-ex (subject to trade mark cllearance) Catch Cyracid 2.0 Diptosol Elmadex Fly tomb 2.0 HO.K.O. HOKOEX Larvo-Mix Meijerin Toukkatuho Cyracid 2 .0 Neo-Larventox C Zero |
Austria Belgium Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Slovakia Slovenia Spain Sweden Switzerland |
Union authorisation | Link to the factsheet |
BEG Larva C50 X BEG Larva C50X LarvEx Konzentrat 50% Larvokill 50 NEPOREX 50 SP Neporex 50SP |
Denmark France Germany |
National authorisation | Link to the factsheet |
Evaluating competent authority:
Greece
R4BP asset number:
EU-0013638-0000
Legal act:
Start date:
01/01/2018
End date:
31/12/2027
Assessment Report
BPC opinions
SE minority opinion cyromazine PT 18.pdf (en) (11/07/2016)
AS-APP_Cyromazine_PT 18_Final opinion.pdf (en) (11/07/2016)
SE minority opinion cyromazine PT 18.pdf (en) (11/07/2016)
AS-APP_Cyromazine_PT 18_Final opinion.pdf (en) (11/07/2016)
Evaluating competent authority:
Greece
Assessment outcome:
Successful
Conclusion date:
11/07/2016
BPC opinions
SE minority opinion cyromazine PT 18.pdf (en) (11/07/2016)
AS-APP_Cyromazine_PT 18_Final opinion.pdf (en) (11/07/2016)
Evaluating competent authority:
Greece
Assessment outcome:
Successful
Conclusion date:
11/07/2016
Assessment Report
BPC opinions
SE minority opinion cyromazine PT 18.pdf (en) (11/07/2016)
AS-APP_Cyromazine_PT 18_Final opinion.pdf (en) (11/07/2016)